**Author details**

Alena Soboleva1,2\*, Natalia Vashurina1 and Andrej Frolov1,2

1 Department of Biochemistry, St. Petersburg State University, St. Petersburg, Russia

2 Leibniz Institute of Plant Biochemistry, Halle (Saale), Germany

\*Address all correspondence to: asoboleva@ipb-halle.de

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**83**

*Individual Glycation Sites as Biomarkers of Type 2 Diabetes Mellitus*

Disord 2008;9:193-201. DOI: 10.1007/

[10] Bilova T, Lukasheva E, Brauch D,

Tarakhovskaya E, et al. A snapshot of the plant glycated proteome: structural, functional, and mechanistic aspects. J Biol Chem 2016;291:7621-7636. DOI:

[11] Tamanna N, Mahmood N. Food processing and Maillard reaction products: effect on human health and nutrition. International Journal of Food Science 2015;2015:ID 526762. DOI:

s11154-008-9079-z

Greifenhagen U, Paudel G,

10.1074/jbc.M115.678581

10.1155/2015/526762

[12] Amadori M. The product of the condensation of glucose and p-phenetidine. Atti Reale AccadNazlLincei 1929;9:68-73

[13] Heyns K, Noack H. Die Umsetzung von D-Fructose mit L-Lysin and L-Arginin und dered Beziehung zu nichtenzymatischen Bräunungsreaktion. Chemische Berichte

[14] Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, et al. The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality. Cell Metabolism 2018;28:337-352. DOI:

[15] Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.

[16] Henning C, Glomb MA. Pathways

Scheijen JLJM, van Horssen J, Amor S,

10.1016/j.cmet.2018.08.014

DOI: 10.2337/diab.40.4.405

s10719-016-9694-y

of the Maillard reaction under physiological conditions. Glycoconj J 2016;33:499-512. DOI: 10.1007/

[17] Wetzels S, Vanmierlo T,

1962;95:720-727

*DOI: http://dx.doi.org/10.5772/intechopen.95532*

[1] Kazi AA, Blonde L. Classification of diabetes mellitus. Clin Lab Med

[2] Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch - Eur J Physiol 2020;472:1273-1298. DOI: 10.1007/

**References**

2001;21:1-13

s00424-020-02417-x

s00125-013-2869-1

wjd.v6.i1.109

[3] Czech MP, Tencerova M, Pedersen DJ, Aouadi M. Insulin signalling mechanisms for

triacylglycerol storage. Diabetologia 2013;56:949-964. DOI: 10.1007/

[5] Lund A, Bagger JI, Christensen M, Knop FK, Vilsbøll T. Glucagon and type 2 diabetes: the return of the alpha cell. Curr Diab Rep 2014;14:1-7. DOI:

[6] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018;14:88-98. DOI:

[7] International Diabetes Federation - Facts & figures. About Diabetes n.d. https://www.idf.org/aboutdiabetes/ what-is-diabetes/facts-figures.html

[8] Valdez R. Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol 2009;3:722-726. DOI: 10.1177/193229680900300417

[9] Ambady R, Chamukuttan S. Early diagnosis and prevention of diabetes in developing countries. Rev Endocr Metab

10.1007/s11892-014-0555-4

10.1038/nrendo.2017.151

(accessed August 19, 2020)

[4] Saisho Y. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes 2015;6:109-124. DOI: 10.4239/

*Individual Glycation Sites as Biomarkers of Type 2 Diabetes Mellitus DOI: http://dx.doi.org/10.5772/intechopen.95532*
